ShouTi Secures $100 Million Series B Financing to Accelerate Development of Life-Changing Medicines Fueled by Advanced Computational, Structure-Based Drug Design Platform

SAN FRANCISCO & SHANGHAI--(BUSINESS WIRE)--ShouTi Secures $100M Series B Financing to Accelerate Development of Medicines Fueled by Advanced Computational, Structure-Based Drug Design Platform

Click to view original post